ANGPT1 and hepatocellular carcinoma: Given the pivotal role of angiogenesis inhibitors in the treatment of solid cancers, investigating angiogenic cytokines such as angiopoietin-1 can yield valuable insights into the progression of HCC (Torimura et al., 2004).